Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada flag Canada · Delayed Price · Currency is CAD
0.7100
+0.0100 (1.43%)
Oct 1, 2025, 10:29 AM EDT

Thiogenesis Therapeutics Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1.843.857.086.20.060.02
Cash & Short-Term Investments
1.843.857.086.20.060.02
Cash Growth
-62.91%-45.62%14.21%9805.77%225.72%-
Accounts Receivable
-0.090.09---
Other Receivables
0.05--0.060.170
Receivables
0.050.090.090.060.170
Prepaid Expenses
0.050.050.080.04-0.03
Total Current Assets
1.943.987.246.290.230.05
Total Assets
1.943.987.246.290.230.05
Accounts Payable
1.480.561.670.310.680.03
Accrued Expenses
--0.04-00.01
Short-Term Debt
----0.460.32
Other Current Liabilities
----0.15-
Total Current Liabilities
1.480.561.710.311.290.36
Total Liabilities
1.480.561.710.311.290.36
Common Stock
16.2116.1415.0111.131.050
Additional Paid-In Capital
----0.040.62
Retained Earnings
-17.59-14.28-11.14-6.18-2.14-0.93
Comprehensive Income & Other
1.841.571.661.03-0.01-0
Shareholders' Equity
0.463.435.535.98-1.06-0.31
Total Liabilities & Equity
1.943.987.246.290.230.05
Total Debt
----0.460.32
Net Cash (Debt)
1.843.857.086.2-0.4-0.3
Net Cash Growth
-62.91%-45.62%14.21%---
Net Cash Per Share
0.040.080.180.24-0.03-0.03
Filing Date Shares Outstanding
46.3146.0244.5738.861210
Total Common Shares Outstanding
46.3146.0244.5738.861210
Working Capital
0.463.435.535.98-1.06-0.31
Book Value Per Share
0.010.070.120.15-0.09-0.03
Tangible Book Value
0.463.435.535.98-1.06-0.31
Tangible Book Value Per Share
0.010.070.120.15-0.09-0.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.